Business Type:Manufacturer
Country/Region:India
Ddu Verified
HOT Rank
8/10
Inorbvict Healthcare India Pvt Limited
We are professional supplier of Endoscopy,X-Ray,Surgicals,Operation Theater Products,ICU Product,Hospital Furniture,Pathology Lab,Gynecology,Pulmology Lab and Reagents.
Business Type:Manufacturer
Country/Region:India
Ddu Verified
HOT Rank
8/10
Lenalidomide (trade name Revlimid) is a derivative of thalidomide introduced in 2004.
It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). Along with several other drugs developed in recent years, lenalidomide has significantly improved overall survival in myeloma (which formerly carried a poor prognosis), although toxicity remains an issue for users.[1] It costs $163,381 per year for the average patient.[